Abstract

Accumulating evidence from experimental animal models suggests that antibodies play a protective role against tuberculosis (TB). However, little is known about the antibodies generated upon Mycobacterium tuberculosis (MTB) exposure in humans. Here, we performed a molecular and functional characterization of the human B‐cell response to MTB by generating recombinant monoclonal antibodies from single isolated B cells of untreated adult patients with acute pulmonary TB and from MTB‐exposed healthcare workers. The data suggest that the acute plasmablast response to MTB originates from reactivated memory B cells and indicates a mucosal origin. Through functional analyses, we identified MTB inhibitory antibodies against mycobacterial antigens including virulence factors that play important roles in host cell infection. The inhibitory activity of anti‐MTB antibodies was directly linked to their isotype. Monoclonal as well as purified serum IgA antibodies showed MTB blocking activity independently of Fc alpha receptor expression, whereas IgG antibodies promoted the host cell infection. Together, the data provide molecular insights into the human antibody response to MTB and may thereby facilitate the design of protective vaccination strategies.

Highlights

  • Accumulating evidence from experimental animal models suggests that antibodies play a protective role against tuberculosis (TB)

  • The frequency of plasmablasts was highest during early acute TB and waned upon drug treatment, whereas serum IgG levels increased over six months of antibiotic combination therapy (Fig 1E)

  • To identify Mycobacterium tuberculosis (MTB)-reactive memory B cells among all circulating memory B cells, we focused our analysis on heparin-binding hemagglutinin (HBHA) as representative MTB antigen and performed flow cytometry with fluorescently labeled HBHA to detect HBHA-reactive memory B cells in these donors compared with TB patients (Fig 2D and E)

Read more

Summary

Introduction

Accumulating evidence from experimental animal models suggests that antibodies play a protective role against tuberculosis (TB). Little is known about the antibodies generated upon Mycobacterium tuberculosis (MTB) exposure in humans. We performed a molecular and functional characterization of the human B-cell response to MTB by generating recombinant monoclonal antibodies from single isolated B cells of untreated adult patients with acute pulmonary TB and from MTB-exposed healthcare workers. The data suggest that the acute plasmablast response to MTB originates from reactivated memory B cells and indicates a mucosal origin. We identified MTB inhibitory antibodies against mycobacterial antigens including virulence factors that play important roles in host cell infection. The data provide molecular insights into the human antibody response to MTB and may thereby facilitate the design of protective vaccination strategies

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.